Search PepX: crystal structure
26 results
Results
| PDB Identifier | Description | Ligand | Receptor | SCOP | pdb.org | |
|---|---|---|---|---|---|---|
  |
1A8K | CRYSTALLOGRAPHIC ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS 1 PROTEASE WITH AN ANALOG OF THE CONSERVED CA-P2 SUBSTRATE: INTERACTIONS WITH FREQUENTLY OCCURRING GLUTAMIC ACID RESIDUE AT P2\' POSITION OF SUBSTRATES | C | AB | Acid proteases |
 |
  |
1A94 | STRUCTURAL BASIS FOR SPECIFICITY OF RETROVIRAL PROTEASES | C | AB | Acid proteases |
|
  |
1JDP | Crystal Structure of Hormone/Receptor Complex | H | BA | Periplasmic binding protein-like I |
|
  |
1K2D | Crystal structure of the autoimmune MHC class II I-Au complexed with myelin basic protein 1-11 at 2.2A | P | AB | MHC antigen-recognition domain |
|
  |
1K8D | crystal structure of the non-classical MHC class Ib Qa-2 complexed with a self peptide | P | A | MHC antigen-recognition domain |
|
  |
1KL3 | an engineered streptavidin with improved affinity for the strep-tag II peptide : SAm1-StrepII | E | AD | Streptavidin-like |
|
  |
1KL5 | an engineered streptavidin with improved affinity for the strep-tag II peptide : SAm2-StrepII | E | AD | Streptavidin-like |
|
  |
1MUJ | Crystal structure of murine class II MHC I-Ab in complex with a human CLIP peptide | C | AB | MHC antigen-recognition domain |
|
  |
1Q3P | Crystal structure of the Shank PDZ-ligand complex reveals a class I PDZ interaction and a novel PDZ-PDZ dimerization | C | A | PDZ domain-like |
|
  |
1R5V | Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T-cell activation | E | AB | MHC antigen-recognition domain |
|
  |
1SKG | Structure-based rational drug design: Crystal structure of the complex formed between Phospholipase A2 and a pentapeptide Val-Ala-Phe-Arg-Ser | B | A | Phospholipase A2. PLA2 |
|
  |
1VGK | The crystal structure of class I Major histocompatibility complex, H-2Kd at 2.0 A resolution | C | A | MHC antigen-recognition domain |
|
  |
1YK0 | structure of natriuretic peptide receptor-C complexed with atrial natriuretic peptide | E | A |
|
|
  |
2DS2 | Crystal structure of mabinlin II | A | BD |
|
|
  |
2NWN | New Pharmacophore for Serine Protease Inhibition Revealed by Crystal Structure of Human Urokinase-type Plasminogen Activator Complexed with a Cyclic Peptidyl Inhibitor, upain-1 | B | A |
|
|
  |
2OIN | crystal structure of HCV NS3-4A R155K muntant | C | DAB |
|
|
  |
2PQ2 | Structure of serine proteinase K complex with a highly flexible hydrophobic peptide at 1.8A resolution | B | A | Subtilisin-like |
|
  |
2QV1 | Crystal structure of HCV NS3-4A V36M mutant | C | DAB |
|
|
  |
3BW9 | Crystal Structure of HLA B*3508 in complex with a HCMV 12-mer peptide from the pp65 protein | C | A | MHC antigen-recognition domain |
|
  |
3BWA | Crystal Structure of HLA B*3508 in complex with a HCMV 8-mer peptide from the pp65 protein | C | A | MHC antigen-recognition domain |
|
  |
3C2G | Crystal complex of SYS-1/POP-1 at 2.5A resolution | C | A |
|
|
  |
3CPL | Crystal Structure of H-2Db in complex with a variant M6A of the NP366 peptide from influenza A virus | E | A |
|
|
  |
3FIE | Crystal structure of Clostridium botulinum neurotoxin serotype F catalytic domain with an inhibitor (inh1) | C | A |
|
|
  |
3FII | Crystal structure of Clostridium botulinum neurotoxin serotype F catalytic domain with an inhibitor (inh2) | B | A |
|
|
  |
3FUR | Crystal Structure of PPARg in complex with INT131 | H | A |
|
|
  |
3GCI | Crystal Structure of the Complex Formed Between a New Isoform of Phospholipase A2 with C-terminal Amyloid Beta Heptapeptide at 2 A Resolution | P | A |
|
